RNXTMICRO

RenovoRx, Inc.

HealthcareBiotechnology
$0.93
$0.00(-2.12%)
52W$0.70
$1.45
Updated Jul 8, 02:00 AM
RSI55
RS Rating48/99
Beta1.44
Volatility80%
F-Score4/9
Mkt Cap$35M
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

RenovoRx, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 48), showing significant lag compared to the market leaders. Earnings contraction of 20% provides fundamental context to the price action. Investors should exercise caution due to high volatility (80% annualized), which requires wider risk management.

Relative Strength
48
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.44
vs S&P 500
ABOVE MKT
52W Position
30%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$0.89
50 SMA > 100 SMA$0.92
100 SMA > 150 SMA$0.93
150 SMA > 200 SMA$0.97

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$0.91+1.77%ABOVE
50 SMA$0.89+4.11%ABOVE
100 SMA$0.92+0.65%ABOVE
150 SMA$0.93-0.61%BELOW
200 SMA$0.97-4.57%BELOW

Price Performance

1D-2.1%
1W-5.4%
1M+4.7%
3M+3.1%
6M-8.2%
YTD+11.1%
1Y-29.7%
3Y-21.8%
52-Week Trading Range30% from low
$0.93
52W Low$0.70
52W High$1.45

Technical Indicators

RSI (14)NEUTRAL
54.6
305070
Setup ScoreCOOL
5/10
Base depth: 33.4%

Risk Profile

Beta
1.44
52W Vol
80%
ATR
$0.05
Max DD (1Y)
-48%

Volume Analysis

Today
407.1K
50D Avg
265.2K
Vol Ratio
1.53x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25+20%
$-0.08
Q3'25+19%
$-0.08
Q4'25+36%
$-0.08
Q1'26-20%
$-0.09
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:+5.20%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+17.26%

Stock Price CAGR

10 Years:-18.60%
5 Years:-33.74%
3 Years:-21.81%
1 Year:-29.73%

Return on Equity

10Y Avg:-707.4%
5Y Avg:-796.5%
3Y Avg:-688.4%
Last Year:-138.6%

Key Metrics

Market Cap$35M
Gross Margin70.9%
Net Margin-9.9%
Piotroski F-Score4/9

Frequently Asked Questions

Is RNXT in an uptrend right now?

RNXT has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is RNXT overbought or oversold?

RNXT's RSI (14) is 55. The stock is in neutral territory, neither overbought nor oversold.

Is RNXT outperforming the market?

RNXT has a Relative Strength (RS) Rating of 48 out of 99. RNXT is currently lagging the broader market.

Where is RNXT in its 52-week range?

RNXT is trading at $0.93, which is 64% of its 52-week high ($1.45) and 30% above its 52-week low ($0.70).

How volatile is RNXT?

RNXT has a Beta of 1.44 and 52-week volatility of 80%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.